| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Transition Therapeutics Inc
| TSE
|
TTH
|
3.65
|
|
0.00
(0.00%)
| 98.26M
|
|
|
Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical
company developing novel therapeutics for disease indications with large ...
| |
| |
|
|
Transition Therapeutics Inc (USA)
| NASDAQ
|
TTHI
|
3.51
|
|
0.00
(0.00%)
| 94.41M
|
|
|
Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical
company developing novel therapeutics for disease indications with large ...
| |
| |
|
|
TRANSITION THERAPEUTICS
| FRA
|
RFYA
|
2.56
|
|
-0.05
(-1.84%)
|
|
|
|
|
|
|
VIA Pharmaceuticals Inc
| OTCMKTS
|
VIAP
|
0.0035
|
|
0.0000
(0.00%)
| 71,962.00
|
|
|
The Company focuses on compounds that target inflammation in the blood vessel
wall, as an approach to treatment of cardiovascular disease.
| |
| |
|
|
MediciNova, Inc.
| NASDAQ
|
MNOV
|
3.35
|
|
+0.78
(30.35%)
| 61.12M
|
|
|
MediciNova, Inc. is a development-stage biopharmaceutical company focused on
acquiring and developing small molecule therapeutics for the treatment of ...
| |
| |
|
|
Bioline RX Ltd
| NASDAQ
|
BLRX
|
1.60
|
|
-0.04
(-2.43%)
| 37.42M
|
|
|
BioLineRX Ltd is an Israel-based company engaged in the development of
therapeutics, from preclinical-stage development to advanced clinical trials,
...
| |
| |
|
|
BioLineRX Ltd.
| TLV
|
BLRX
|
59.50
|
|
-0.20
(-0.34%)
| 109.31M
|
|
|
BioLineRX Ltd is an Israel-based company engaged in the development of
therapeutics, from preclinical-stage development to advanced clinical trials,
...
| |
| |
|
|
BIOLINE RX LTD
| OTCMKTS
|
BLNEF
|
0.210
|
|
0.000
(0.00%)
| 47.92M
|
|
|
|
|
